Sharma B, Wyeth R P, Gimenez H J, Franciosa J A
Am J Cardiol. 1986 Dec 1;58(13):1161-6. doi: 10.1016/0002-9149(86)90375-9.
Fourteen patients with acute myocardial infarction (duration of chest pain 5 +/- 2 hours) received intracoronary infusion of prostaglandin E1 (PGE1) and streptokinase. Intracoronary PGE1 was followed by intracoronary streptokinase in 10 patients (group A), with successful recanalization in all patients. Of 4 patients in whom recanalization failed with intracoronary streptokinase given first (group B), 2 had successful recanalization after addition of intracoronary PGE1. Immediately after successful recanalization, left ventricular ejection fraction increased from 50 +/- 9% to 62 +/- 10% (p less than 0.0008), left ventricular end-diastolic pressure decreased from 20 +/- 10 to 16 +/- 10 mm Hg (p less than 0.05) and stroke volume index increased from 34 +/- 10 to 44 +/- 12 ml/m2 (p less than 0.02). Infarct segment shortening improved from 9 +/- 5 to 18 +/- 4% (p less than 0.0002). Transient hypotension in 1 patient was the only complication. Follow-up catheterization in recanalized patients at 2 to 10 days showed maintained improvement in left ventricular global and infarct segment function. Reocclusion occurred in 1 patient. Thus, intracoronary infusion of PGE1 was effective in establishing reperfusion in all patients when followed by streptokinase and was associated with immediately improved left ventricular global and regional function. PGE1 deserves further evaluation in acute myocardial infarction.
14例急性心肌梗死患者(胸痛持续时间为5±2小时)接受了冠状动脉内输注前列腺素E1(PGE1)和链激酶治疗。10例患者(A组)先进行冠状动脉内PGE1输注,随后进行冠状动脉内链激酶输注,所有患者均成功再灌注。4例先给予冠状动脉内链激酶但再灌注失败的患者(B组)中,2例在加用冠状动脉内PGE1后成功再灌注。成功再灌注后即刻,左心室射血分数从50±9%增加到62±10%(p<0.0008),左心室舒张末期压力从20±10降至16±10mmHg(p<0.05),每搏量指数从34±10增加到44±12ml/m2(p<0.02)。梗死节段缩短率从9±5%改善到18±4%(p<0.0002)。仅1例患者出现短暂性低血压这一并发症。再灌注患者在2至10天进行的随访导管检查显示左心室整体和梗死节段功能持续改善。1例患者发生再闭塞。因此,冠状动脉内输注PGE1在随后给予链激酶时对所有患者建立再灌注均有效,并伴有左心室整体和局部功能即刻改善。PGE1在急性心肌梗死中值得进一步评估。